On June 30, 2021 FairJourney Biologics S.A. (FJB), leaders in the discovery and optimization of antibodies, reported the launch of "THE ANTIBODY SERIES" – a 1-day conference bringing together top experts in the antibody field to explore the latest innovation within antibody drug discovery (Press release, FairJourney Biologics, JUN 30, 2021, View Source [SID1234584506]). The conference is being launched in Porto, Portugal, celebrating FairJourney Biologics’ inauguration of their new purpose built, state-of-the-art facilities. Online registration to the event has been made available free for a limited period here: Online Registration.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
THE ANTIBODY SERIES takes place on September 9th 2021 (8:45 am BST) and will play host to a panel of influential and international speakers ranging from Biotechs, Universities and Nobel Prize Laureate including:
Sir Gregory Winter, Winner of the 2018 Chemistry Nobel Prize
Hans Clevers (Principle Investigator at Hubrecht Institute)
Ton Logtenberg (University Medical Center Utrecht)
John McCafferty (CSO of IONTAS)
Maria Pajuelo (CSO of FJB)
Daniela Teixeira (COO FJB)
Teresa Barata (Head of Protein Production and Characterization at Flow Eighteen38)
Allan Jensen (VP of Lundbeck)
Mihri Tuna (CSO of Adaptate)
Tatiana Novobrantseva (CSO of Verseau)
Tim Van Hauwermeiren (CEO argenx)
Hans De Haard (CSO argenx)
THE ANTIBODY SERIES will be broadcast live from Porto to enable audiences globally the chance to participate and watch the conference, with the in-person event attended by notable invitees across Industry and Academia.
António Parada, CEO of FairJourney Biologics commented: "We believe our customers and clients will benefit greatly from the decades of experience, innovation and insight each speaker brings to this new event. Having such a diverse panel of speakers, from leading industry to academia, including Nobel Laureate at our first event is truly encouraging and we look forward to sharing this special event with our community and growing the platform."